Clinical Trial Update: CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating CAR T and PD-1 knockout engineered T cells for advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: The First Affiliated Hospital of Guangdong Pharmaceutical University | Conditions: Advanced Esophageal Cancer | Phase 1, Phase 2 | Status: UNKNOWN